Clinical Trials Browser

Uveal Melanoma, Astrocytoma, Urinary Bladder Neoplasms, Brain Neoplasms, Carcinoma, Renal Cell, Craniopharyngioma, Esophageal Neoplasms, Hodgkin Disease, Kidney Neoplasms, Lymphoma, Lymphoma, Non-Hodgkin, Melanoma, Meningeal Neoplasms, Neoplasms, Germ Cell and Embryonal, Pancreatic Neoplasms, Pinealoma, Lymphoma, T-Cell, Cutaneous, Lymphoma, AIDS-Related, Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Nephroma, Mesoblastic, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Intraocular Lymphoma

NCT00406900 2006-12-06

Melanoma Inhibitory Activity (MIA): A Serological Marker for Metastatic Uveal Melanoma

Unknown

560 enrolled

Dermatologic

Uveal Melanoma, Melanoma, Neoplasm Metastasis

Clinical Trials

Uveal Melanoma - Comparative Study

ISABELLA

The Role of Genetic Mutations and of Circulating mRNAs in Uveal Melanoma

ICIPRESIST19

BAP1 Testing in Instance Choroidal Nevi or Uveal Melanoma

The Role of Inflammation in Ocular Tumours

Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom

Melanoma Inhibitory Activity (MIA): A Serological Marker for Metastatic Uveal Melanoma